A Study to Learn About Effect of Sisunatovir in Healthy Adult Male Participants
NCT05873764
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class
Conditions
Respiratory Syncytial Virus Infections
Interventions
DRUG:
200 mg RV521/78 µCi [ 14C]-RV521.
Sponsor
Pfizer